Quick Answer
ZIMMER BIOMET HOLDINGS, INC. reported Operating Income Loss of $1.10 billion for the year ending 2025.
- ZIMMER BIOMET HOLDINGS, INC. showed a decrease of -14.6% in Operating Income Loss from 2024 to 2025.
- This data is from ZIMMER BIOMET HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2008 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $271.60 million | Q1 2011: $297.20 million | Q2 2011: $259.10 million | Q3 2011: $266.60 million | Q1 2012: $295.60 million | Q2 2012: $301.90 million | Q3 2012: $249.40 million | Q1 2013: $298.20 million | Q2 2013: $210.40 million | Q3 2013: $211.70 million | Q1 2014: $300.10 million | Q2 2014: $260.90 million | Q3 2014: $255.20 million | Q1 2015: $269.90 million | Q2 2015: -$132.10 million | Q3 2015: $116.00 million | Q1 2016: $245.50 million | Q2 2016: $201.60 million | Q3 2016: $195.50 million | Q1 2017: $348.10 million | Q2 2017: $280.10 million | Q3 2017: $211.20 million | Q1 2018: $305.00 million | Q2 2018: $296.00 million | Q3 2018: $223.30 million | Q1 2019: $350.20 million | Q2 2019: $204.70 million | Q3 2019: $245.80 million | Q1 2020: -$456.00 million | Q2 2020: -$171.70 million | Q3 2020: $299.20 million | Q1 2021: $258.70 million | Q2 2021: $224.80 million | Q3 2021: $243.00 million | Q1 2022: $198.40 million | Q2 2022: $280.90 million | Q3 2022: $245.30 million | Q1 2023: $327.30 million | Q2 2023: $329.60 million | Q3 2023: $266.60 million | Q1 2024: $265.90 million | Q2 2024: $351.30 million | Q3 2024: $279.50 million | Q1 2025: $292.30 million | Q2 2025: $300.00 million | Q3 2025: $351.30 million.
- Over the full 18 years of available data (2008 to 2025), ZIMMER BIOMET HOLDINGS, INC.'s Operating Income Loss has grown by 0.7%.
- Historical annual values: Fiscal year 2025: $1.10 billion | Fiscal year 2024: $1.29 billion | Fiscal year 2023: $1.28 billion | Fiscal year 2022: $696.30 million | Fiscal year 2021: $860.30 million | Fiscal year 2020: $83.10 million | Fiscal year 2019: $1.14 billion | Fiscal year 2018: $33.80 million | Fiscal year 2017: $799.30 million | Fiscal year 2016: $821.10 million | Fiscal year 2015: $467.30 million | Fiscal year 2014: $1.04 billion | Fiscal year 2013: $1.07 billion | Fiscal year 2012: $1.05 billion | Fiscal year 2011: $1.02 billion | Fiscal year 2010: $916.70 million | Fiscal year 2009: $1.02 billion | Fiscal year 2008: $1.09 billion.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: